- Details
- Description
Packaging Size:
30 tablets per pack
Strength:
As stated on the product packaging
Composition:
Avapritinib
Treatment:
Certain gastrointestinal stromal tumors (GIST) and other approved conditions involving specific molecular alterations, according to the applicable indication and physician’s prescription.
Form:
Tablet
Brand:
LuciAvap
Quantity Unit:
Tablets
Manufacturer:
Lucius Pharma
LuciAvap (Avapritinib) is a prescription medicine used as a targeted therapy for certain gastrointestinal stromal tumors (GIST) and other conditions involving specific molecular changes. Avapritinib is a tyrosine kinase inhibitor that targets specific abnormal signaling pathways involved in the growth of certain tumor cells.
LuciAvap is intended for oral use and should be used according to the prescribing physician’s instructions and under appropriate medical supervision.
